Barrett Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Barrett Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,000	Closed	-$35K	–	415
2017 Q3	$35K	Sell	3,000 -4,800	-62%	-$53.8K	﹤0.01%	260
2017 Q2	$82K	Hold	7,800	–	–	0.01%	209
2017 Q1	$86K	Hold	7,800	–	–	0.01%	191
2016 Q4	$106K	Hold	7,800	–	–	0.01%	178
2016 Q3	$96K	Hold	7,800	–	–	0.01%	179
2016 Q2	$86K	Buy	7,800 +1,600	+26%	+$17.9K	0.01%	182
2016 Q1	$68K	Buy	6,200 +2,100	+51%	+$26.5K	0.01%	195
2015 Q4	$71K	Buy	4,100 +3,700	+925%	+$66.3K	0.01%	189
2015 Q3	$8K	Buy	+400	New	+$9.17K	﹤0.01%	280

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Barrett Asset Management's SCMP Position: Q4 2017 in Review

Barrett Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 3,000 shares — an estimated $35K sold.

Barrett Asset Management first reported a position in SCMP in Q3 2015 and held it in 9 quarters. The position peaked at $106K in Q4 2016. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Barrett Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Barrett Asset Management sold 3,000 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $35K.
Barrett Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 9 quarters.
Barrett Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $106K in Q4 2016.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Barrett Asset Management's 13F filing for Q4 2017, filed 7 Feb 2018.